Suppr超能文献

肝硬化患者的血管加压素释放与水代谢

Vasopressin release and water metabolism in patients with cirrhosis.

作者信息

Salerno F, Del Bo A, Maggi A, Marabini M, Maffi M, Borroni G M, Moser P

机构信息

Instituto di Medicina Interna, Università degli Studi di Milano, Italy.

出版信息

J Hepatol. 1994 Nov;21(5):822-30. doi: 10.1016/s0168-8278(94)80245-9.

Abstract

Water retention is a complication in many patients with cirrhosis, usually attributed to excessive release of arginine vasopressin. To investigate the responsiveness of arginine vasopressin to osmotic and non-osmotic stimuli and its relationship to free water excretion, we studied 19 patients with cirrhosis under three different conditions: 45 min with legs raised to 60 degrees, to expand the central blood volume; infusion of 1000 ml of 0.45% saline solution to reduce plasma osmolality; and rapid injection of 50 ml of 2 M NaCl to increase plasma osmolality. Both expansion of central blood volume and decrease of plasma osmolality significantly reduced plasma vasopressin levels (from 2.1 +/- 0.6 to 1.39 +/- 0.3 pg/ml, p < 0.04; and from 1.09 +/- 0.25 to 0.41 +/- 0.13 pg/ml, p < 0.0001). The changes in free water excretion differentiated two subgroups of patients during each test: excretors and non-excretors. In the excretors, increased free water excretion was associated with suppressed vasopressin levels (below 0.5 pg/ml) and normal renal function. In the non-excretors, inability to improve free water excretion was associated with high vasopressin levels or with reduced distal delivery of the glomerular filtrate, except in some cases where vasopressin levels had fallen below 0.5 pg/ml and renal function was normal. For these cases the presence of other vasopressin-independent antidiuretic mechanisms is conceivable. The injection of hypertonic saline solution caused significant rises in plasma osmolality (from 287 +/- 1.9 to 292 +/- 1.6 mmol/kg, p < 0.05) and in plasma vasopressin levels (from 1.13 +/- 0.29 to 2.86 +/- 0.52 pg/ml, p < 0.05). These results suggest that vasopressin release in patients with cirrhosis is normally responsive to osmotic and non-osmotic stimuli, although our results show a lower theoretical osmolar threshold for suppression of vasopressin release in non-excretors than in excretors (276 vs 284 mmol/kg).

摘要

水潴留是许多肝硬化患者的一种并发症,通常归因于精氨酸加压素的过度释放。为了研究精氨酸加压素对渗透压和非渗透压刺激的反应性及其与自由水排泄的关系,我们在三种不同条件下对19例肝硬化患者进行了研究:将双腿抬高至60度45分钟,以扩充中心血容量;输注1000毫升0.45%的盐溶液以降低血浆渗透压;快速注射50毫升2M氯化钠以增加血浆渗透压。中心血容量扩充和血浆渗透压降低均显著降低了血浆加压素水平(从2.1±0.6降至1.39±0.3皮克/毫升,p<0.04;从1.09±0.25降至0.41±0.13皮克/毫升,p<0.0001)。在每次测试期间,自由水排泄的变化区分出两组患者:排泄者和非排泄者。在排泄者中,自由水排泄增加与加压素水平受抑制(低于0.5皮克/毫升)及肾功能正常有关。在非排泄者中,无法改善自由水排泄与加压素水平高或肾小球滤过液远端输送减少有关,但在某些情况下,加压素水平已降至低于0.5皮克/毫升且肾功能正常除外。对于这些情况,可以想象存在其他不依赖加压素的抗利尿机制。注射高渗盐溶液导致血浆渗透压显著升高(从287±1.9升至292±1.6毫摩尔/千克,p<0.05)和血浆加压素水平升高(从1.13±0.29升至2.86±0.52皮克/毫升,p<0.05)。这些结果表明,肝硬化患者中加压素的释放通常对渗透压和非渗透压刺激有反应,尽管我们的结果显示,非排泄者中抑制加压素释放的理论渗透压阈值低于排泄者(276对284毫摩尔/千克)。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验